No significant differences in autocrine IL-10 production were noted between U- and M-CLL cells following stimulation with resiquimod with or without IL-2 (Supplementary Figures 4B, 6B). This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.